Connect with us


Weekly Market Pulse: The Cure For High Prices

There’s an old Wall Street maxim that the cure for high commodity prices is high commodity prices. As prices rise two things will generally limit the scope…



There’s an old Wall Street maxim that the cure for high commodity prices is high commodity prices. As prices rise two things will generally limit the scope of the increase. Demand will wane as consumers just use less or find substitutes. Supply will also increase as the companies that extract these raw materials open new mines, grow more crops or drill new wells. The combination of those two will act to bring prices back down until the process reverses. As prices fall, demand rises and supply is constrained until prices start to rise again. We’ve seen this cycle many times throughout history so we know the sequence of events. What we don’t know is the time within which these things will occur. How high do prices have to go before we get demand destruction? How long does it take to bring a new mine into production and increase supply?

We can see the same supply/demand dynamic across the entire economy. Prices rise until, at some point we see a drop in demand, inventories build up and production has to be scaled back; we get a recession. We also face the same time issue across the entire economy as we do with the commodity markets. How high do prices have to rise before demand wanes? How much does demand have to drop before inventory build up requires producers to scale back production? How much will they have to scale back and how many people will have to be laid off in the process? The cycle this time around is more complicated than normal I suppose, by a pandemic and now a war, but I don’t have much doubt that the process will play out as it has in the past. But when? I don’t know obviously, but I do know that we are stress testing the economy with prices right now.

The economy right this minute is not in danger of recession, at least based on the indicators we follow. We have seen some early warnings such as the inversion of the 10/7 year Treasury yields but that is generally a very early warning of recession. Of course, at the rate prices and interest rates are rising recently, that may not prove true this time but we would still expect to see other indicators turn negative prior to the onset of recession. Other parts of the curve would still invert and credit spreads would still widen. And right before recession, the yield curve would probably steepen as short term rates fall rapidly; the market will not wait for the Fed to start lowering rates before rendering its own verdict on the economy.

But the price hikes may be reaching a tipping point. The Chicago Fed tracks weekly credit and debit card activity, mobility (gas consumption and retail foot traffic) and consumer sentiment to project monthly retail sales ex-autos. The latest readings are showing a sizable drop off from February to March; their current projection is for March retail sales to fall over 3% and over 4% adjusted for inflation. I don’t think we should make too much of this yet since we knew that the previous pace of retail sales was not sustainable; retail sales were well above the pre-COVID trend. We also don’t know yet how much, if any, service spending has picked up although there are some indications that it has. This may be nothing more than a reallocation of spending rather than a big slowdown but it merits watching closely.

We certainly don’t see any indication that bond traders are concerned about recession yet. The 10 year Treasury yield rose 34 basis points last week to end right near 2.5% and the entire curve basically shifted up; the 10/2 year spread widened – a whole basis point – to 18. Bonds are now down more than stocks YTD, on pace for their worst quarter since 1980. The Aggregate bond ETF (AGG) is down nearly 7% this quarter.

The S&P 500 is still down on the year too even after a decent – and confounding I might add – rally last week. But more interesting is that in a down year, the standard 60/40 allocation of stocks and bonds has done worse than just owning the S&P 500. Owning bonds as a diversifier, as a hedge against a bad stock market, has not worked out this year.

What has worked is owning commodities and gold, both of which are up on the year. What has also worked is to own value and dividend stocks; this has very much been a correction of growth stocks.

We have maintained a short duration bond portfolio this year because we expected rates to continue rising, if not quite this rapidly. But this bond bear market – and yes I think that is the appropriate term here – won’t last forever. Neither, by the way, will the bull market in commodities. At some point the demand destruction I talked about above will happen and we know generally what will happen when it does. Commodity prices will fall, the economy will slow and the bond market will start to price in fewer rates hikes. If it goes past some point, the bond market will start to price in rate cuts (which forward curves are already doing in late 2023). An investor is faced with two competing desires at this point. Let momentum work and keep our current allocations to commodities (which have risen due to gains) intact or rebalance to restore our bond allocations (which have fallen due to losses)? Considering investor sentiment regarding both assets, I’d suggest that rebalancing probably makes some sense right now. Investors seem too eager to buy commodities and too reluctant to buy bonds. If nothing else, it is the conservative choice.

Investors can also start to consider some tactical choices. Once rates have hit a peak (so easy to write, so hard to see), an investor who has held short and intermediate term bonds can start to extend maturities in anticipation of a declining rate environment. Way back when this recovery started I looked at the long term trends and decided that somewhere around 2.5% would be the top in the 10 year Treasury rate for this cycle. That was based on nothing more than extrapolating the long term trend and assuming that the long term downtrend in rates would stay intact. It is far from scientific but I think it helps to have an idea of where the long term trends are headed. Anyway, the pace of rising rates has surprised me so we’ve arrived at my target before I expected. And I don’t know for sure that the long term rate downtrend will stay intact. But if it does, the time for extending duration and positioning for capital gains in bonds is probably near.

Once recession looks inevitable, there will be an opportunity for another tactical change. As we near recession, as those other indicators start to send warnings, an investor could decide to make a short term change in their strategic allocation. If your strategic allocation is to hold 30% in bonds, you might choose to shift to a 40% bond allocation or if you have a lot of conviction, 50% bonds. Changes to your strategic allocation should be rare though because they tend to be hard to reverse. If you shift to a more conservative allocation and there is no recession, you should shift back to your original strategic allocation. But that is very hard to do; we humans aren’t great at admitting our mistakes.

One last thing to consider is that this doesn’t have to unfold this way. Commodity prices and inflation more generally, could fall before demand destruction sets in. The rise in prices has been driven by multiple factors, some of them on the supply side, some on the demand side. The Ukraine war has added an element of uncertainty that could be relieved – to some degree – by a sudden resolution. The anticipated drop in goods demand may not precipitate an inventory correction; inventory to sales ratios remain quite low. The future of high prices inducing demand destruction and a recession fairly soon is just one potential future. Unfortunately, our crystal balls are all cracked so we’ll just have to wait and see how things unfold.


The environment continues to be marked by a rising dollar and rising rates. The dollar remains in its long term range and isn’t worrisome right now. Rates, on the other hand, are rising rapidly and seem likely to have an impact on the housing market, where mortgage rates have risen dramatically recently. I saw 30 year mortgages being quoted at 5% last week, up from an average of 3.3% a year ago. And rates were under 3% at one point in this cycle. Some home buyers are going to have to shift to a lower price point. Still, housing inventory is quite low and a lot of buyers – especially new home buyers – have locked in lower rates so this might take some time to have a big impact. And for those with existing mortgages, we seem to have learned our lesson about variable rates; over 95% of outstanding mortgages are fixed rate.

Markets Review

Commodities resumed their run last week after a brief pause. That was driven mainly by energy with natural gas and crude oil up 15.4% and 10.5% respectively. Natural gas prices rose on news that the US agreed to supply an additional 15 billion cubic feet of LNG to Europe this year. Nat gas prices have been on the rise for some time but I don’t think this deal changes the overall supply/demand picture. We have a finite amount of LNG capacity and we’re using it all right now so any shift to Europe will just be a reallocation of what we were sending to Asia. Not bad news for producers maybe since they’ll likely get a better price but the amount of gas being exported isn’t going to change much.

Agricultural commodities have also risen strongly this year. That isn’t just due to the potential disruption of supply from Russian and Ukraine but also due to problems with fertilizer supply. The problem there has as much to do with high natural gas as the war. Russia is an exporter of fertilizer but the US is a larger producer. US farmers are seeing higher fertilizer bills but the impact will be felt much more acutely in other countries. To add one more element of uncertainty, there is also a shortage of glycophosate, a widely used week killer. It’s tough being a farmer these days. Okay, it’s always been tough to be a farmer but this year is turning out to be a special kind of tough.

There wasn’t much difference in returns for large cap growth and value last week but value continued to lead in small and mid-cap.

Energy and materials were the big winners last week but most sectors were up last week, healthcare the exception.

Credit spreads have narrowed over the last two weeks and the volatility index has fallen to the low 20s. The volatility index is in an uptrend that started in November. After falling from the high 30s, it may be ready for another run higher. I still don’t think sentiment got negative enough at the recent low to make this a reliable bottom. We may need to revisit the lows before we can put this correction behind us and that would likely push the VIX higher again.

We can’t know how the future will unfold but we should know history and basic economics. Real commodity prices have been falling for decades through a series of booms and busts. We are obviously in one of those boom periods right now but how long it will last is something we can’t know in advance. But we know that the bust will come, it is only a matter of time. We can also look at historical bond returns and know that down periods like we’re in now are inevitably followed by up periods. Seems like a great time to rebalance your portfolio back to its strategic, long term allocation. It may not be the top for commodities or the bottom for bonds but we’re a lot closer now than we were just at the beginning of this year.

Joe Calhoun

Read More

Continue Reading


China Auto Sales Jump 55% Year Over Year As Price Cuts Continue To Move NEV Metal

China Auto Sales Jump 55% Year Over Year As Price Cuts Continue To Move NEV Metal

Retail sales of passenger vehicles scorched higher in May,…



China Auto Sales Jump 55% Year Over Year As Price Cuts Continue To Move NEV Metal

Retail sales of passenger vehicles scorched higher in May, with 1.76 million units sold, according to preliminary data from the China Passenger Car Association released this week. 

The sales figure represents 8% growth from the month prior. As has been the case over the last several years, new energy vehicles continue to grow disproportionately to the rest of the sector, driving sales higher.

Last month 557,000 NEVs were sold, growth of 55% year over year and 6% sequentially, according to a Bloomberg wrap up of the data. 

The sales boost comes as the country slashed prices to move metal throughout the first 5 months of the year. In late May we noted that China's auto industry association was urging automakers to "cool" the hype behind price cuts that were sweeping across the country. 

The price cuts were getting so egregious that the China Association of Automobile Manufacturers went so far as to put out a message on its official WeChat account, stating that "a price war is not a long-term solution". Instead "automakers should work harder on technology and branding," it said at the time.

Recall we wrote in May that most major automakers were slashing prices in China. The move is coming after lifting pandemic controls failed to spur significant demand in China, the Wall Street Journal reported last month. Ford and GM will be joined by BMW and Volkswagen in offering the discounts and promotions on EVs, the report says. 

At the time, Ford was offering $6,000 off its Mustang Mach-E, putting the standard version of its EV at just $31,000. In April, prior to the discounts, only 84 of the vehicles were sold, compared to 1,500 sales in December. There was some pulling forward of demand due to the phasing out of subsidies heading into the new year, and Ford had also cut prices by about 9% in December. 

A spokesperson for Ford called it a "stock clearance" at the time. 

Discounts at Volkswagen ranged from around $2,200 to $7,300 a car. Its electric ID series is seeing price cuts of almost $6,000. The company called the cuts "temporary promotions due to general reluctance among car buyers, the new emissions rule and discounts offered by competitors."

China followed suit, and thus, now we have the sales numbers to prove it...

Tyler Durden Wed, 06/07/2023 - 20:00

Read More

Continue Reading


World Bank: Global Economic Growth Expected To Slow To 2008 Levels

World Bank: Global Economic Growth Expected To Slow To 2008 Levels

Authored by Michael Maharrey via,

Most people in the mainstream…



World Bank: Global Economic Growth Expected To Slow To 2008 Levels

Authored by Michael Maharrey via,

Most people in the mainstream concede that the economy is heading for a recession, but the consensus seems to be that downturn will be short and shallow. Projections by the World Bank undercut that optimism.

According to the World Bank, global growth in 2023 will slow to the lowest level since the 2008 financial crisis.

In other words, the World Bank is predicting the beginning of Great Recession 2.0.

You might recall that the Great Recession was neither short nor shallow.

In fact, World Bank Group chief economist and senior vice president Indermit Gill said, “The world economy is in a precarious position.”

According to the World Bank’s new Global Economic Prospects report, global growth is projected to decelerate to 2.1% this year, falling from 3.1% in 2022. The bank forecasts a significant slowdown during the last half of this year.

That would match the global growth rate during the 2008 financial crisis.

According to the World Bank, higher interest rates, inflation, and more restrictive credit conditions will drive the economic downturn.

The report forecasts that growth in advanced economies will slow from 2.6% in 2022 to 0.7% this year and remain weak in 2024.

Emerging market economies will feel significant pain from the economic slowdown. Yahoo Finance reported, “Higher interest rates are a problem for emerging markets, which already were reeling from the overlapping shocks of the pandemic and the Russian invasion of Ukraine. They make it harder for those economies to service debt loans denominated in US dollars.”

The World Bank report paints a bleak picture.

The world economy remains hobbled. Besieged by high inflation, tight global financial markets, and record debt levels, many countries are simply growing poorer.”

Absent from the World Bank analysis is any mention of how more than a decade of artificially low interest rates and trillions of dollars in quantitative easing by central banks created the wave of inflation that continues to sweep the globe, along with massive levels of debt and all kinds of economic bubbles.

If you listen to the mainstream narrative, you would think inflation just came out of nowhere, and central banks are innocent victims nobly struggling to save the day by raising interest rates. Pundits fret about rising rates but never mention that rates were only so low for so long because of the actions of central banks. And they seem oblivious to the consequences of those policies.

But being oblivious doesn’t shield you from the impact of those consequences.

In reality, central banks and governments implemented policies intended to incentivize the accumulation of debt. They created trillions of dollars out of thin air and showered the world with stimulus, unleashing the inflation monster. And now they’re trying to battle the dragon they set loose by raising interest rates. This will inevitably pop the bubble they intentionally blew up. That’s why the World Bank is forecasting Great Recession-era growth. All of this was entirely predictable.

After all, artificially low interest rates are the mother’s milk of a global economy built on easy money and debt. When you take away the milk, the baby gets hungry. That’s what’s happening today. With interest rates rising, the bubbles are starting to pop.

And it’s probably going to be much worse than most people realize. There are more malinvestments, more debt, and more bubbles in the global economy today than there were in 2008. There is every reason to believe the bust will be much worse today than it was then.

In other words, you can strike “short” and “shallow” from your recession vocabulary.

Even the World Bank is hinting at this.

Tyler Durden Wed, 06/07/2023 - 15:20

Read More

Continue Reading


DNAmFitAge: Biological age indicator incorporating physical fitness

“We expect DNAmFitAge will be a useful biomarker for quantifying fitness benefits at an epigenetic level and can be used to evaluate exercise-based interventions.”…



“We expect DNAmFitAge will be a useful biomarker for quantifying fitness benefits at an epigenetic level and can be used to evaluate exercise-based interventions.”

Credit: 2023 McGreevy et al.

“We expect DNAmFitAge will be a useful biomarker for quantifying fitness benefits at an epigenetic level and can be used to evaluate exercise-based interventions.”

BUFFALO, NY- June 7, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 15, Issue 10, entitled, “DNAmFitAge: biological age indicator incorporating physical fitness.”

Physical fitness is a well-known correlate of health and the aging process and DNA methylation (DNAm) data can capture aging via epigenetic clocks. However, current epigenetic clocks did not yet use measures of mobility, strength, lung, or endurance fitness in their construction. 

In this new study, researchers Kristen M. McGreevy, Zsolt Radak, Ferenc Torma, Matyas Jokai, Ake T. Lu, Daniel W. Belsky, Alexandra Binder, Riccardo E. Marioni, Luigi Ferrucci, Ewelina Pośpiech, Wojciech Branicki, Andrzej Ossowski, Aneta Sitek, Magdalena Spólnicka, Laura M. Raffield, Alex P. Reiner, Simon Cox, Michael Kobor, David L. Corcoran, and Steve Horvath from the University of California Los Angeles, University of Physical Education, Altos Labs, Columbia University Mailman School of Public Health, University of Hawaii, University of Edinburgh, National Institute on Aging, Jagiellonian University, Pomeranian Medical University in Szczecin, University of Łódź, Central Forensic Laboratory of the Police in Warsaw, Poland, University of North Carolina at Chapel Hill, University of Washington, and University of British Columbia develop blood-based DNAm biomarkers for fitness parameters including gait speed (walking speed), maximum handgrip strength, forced expiratory volume in one second (FEV1), and maximal oxygen uptake (VO2max) which have modest correlation with fitness parameters in five large-scale validation datasets (average r between 0.16–0.48). 

“These parameters were chosen because handgrip strength and VO2max provide insight into the two main categories of fitness: strength and endurance [23], and gait speed and FEV1 provide insight into fitness-related organ function: mobility and lung function [8, 24].”

The researchers then used these DNAm fitness parameter biomarkers with DNAmGrimAge, a DNAm mortality risk estimate, to construct DNAmFitAge, a new biological age indicator that incorporates physical fitness. DNAmFitAge was associated with low-intermediate physical activity levels across validation datasets (p = 6.4E-13), and younger/fitter DNAmFitAge corresponds to stronger DNAm fitness parameters in both males and females. 

DNAmFitAge was lower (p = 0.046) and DNAmVO2max is higher (p = 0.023) in male body builders compared to controls. Physically fit people had a younger DNAmFitAge and experienced better age-related outcomes: lower mortality risk (p = 7.2E-51), coronary heart disease risk (p = 2.6E-8), and increased disease-free status (p = 1.1E-7). These new DNAm biomarkers provide researchers a new method to incorporate physical fitness into epigenetic clocks.

“Our newly constructed DNAm biomarkers and DNAmFitAge provide researchers and physicians a new method to incorporate physical fitness into epigenetic clocks and emphasizes the effect lifestyle has on the aging methylome.”

Read the full study: DOI: 

Corresponding Authors: Kristen M. McGreevy, Zsolt Radak, Steve Horvath

Corresponding Emails:,, 

Keywords: epigenetics, aging, physical fitness, biological age, DNA methylation

Sign up for free Altmetric alerts about this article:


About Aging-US:

Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways.

Please visit our website at​​ and connect with us:

  • SoundCloud
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LabTube
  • LinkedIn
  • Reddit
  • Pinterest


Click here to subscribe to Aging publication updates.

For media inquiries, please contact


Aging (Aging-US) Journal Office

6666 E. Quaker Str., Suite 1B

Orchard Park, NY 14127

Phone: 1-800-922-0957, option 1


Read More

Continue Reading